TY - JOUR
T1 - An update on vitamin D and B deficiency in the pathogenesis and treatment of diabetic neuropathy: a narrative review
AU - Alam, Uazman
AU - Nelson, Andrew J
AU - Cuthbertson, Daniel J
AU - Malik, Rayaz A
N1 - Funding Information:
1Department of Eye & Vision Sciences, Diabetes & Endocrinology Research & the Pain Research Institute, Institute of Ageing & Chronic Disease, University of Liverpool & Aintree University Hospital NHS Foundation Trust, Liverpool, L9 7AL, United Kingdom 2Department of Diabetes & Endocrinology, Royal Liverpool & Broadgreen University NHS Hospital Trust, Liverpool, L7 8XP, United Kingdom 3Division of Endocrinology, Diabetes & Gastroenterology, University of Manchester, Manchester, M13 9MT, United Kingdom 4Weill Cornell Medicine – Qatar, Qatar Foundation – Education City, P.O. Box 24144, Doha, Qatar 5Institute of Cardiovascular Sciences, University of Manchester, Manchester, M13 9MT, United Kingdom 6School of Healthcare Science, Manchester Metropolitan University, Manchester, M15 6BH, United Kingdom *Author for correspondence: Tel.: 0151 529 5920; [email protected]
Publisher Copyright:
© 2018 2018 Future Medicine Ltd.
PY - 2018/8
Y1 - 2018/8
N2 - Diabetic peripheral neuropathy (DPN) is highly prevalent and affects up to 50% of patients with diabetes. Painful neuropathic symptoms may occur in a third of patients with diabetes and is a major cause of sleep disturbance, morbidity and poor quality of life. Effective treatment of DPN remains a major challenge as current therapeutic options have a number of undesirable side effects and only provide a partial response to neuropathic pain. Furthermore, there are a lack of treatments that modulate the natural history of DPN. A growing body of evidence suggests that vitamin B and vitamin D may have analgesic effects and neuroprotective benefits in DPN. This narrative review explores the role of these vitamins in DPN. Given their limited side effects, further mechanistic studies and good quality randomized controlled trials of their putative analgesic ability are required to define the role of vitamin B and D in DPN.
AB - Diabetic peripheral neuropathy (DPN) is highly prevalent and affects up to 50% of patients with diabetes. Painful neuropathic symptoms may occur in a third of patients with diabetes and is a major cause of sleep disturbance, morbidity and poor quality of life. Effective treatment of DPN remains a major challenge as current therapeutic options have a number of undesirable side effects and only provide a partial response to neuropathic pain. Furthermore, there are a lack of treatments that modulate the natural history of DPN. A growing body of evidence suggests that vitamin B and vitamin D may have analgesic effects and neuroprotective benefits in DPN. This narrative review explores the role of these vitamins in DPN. Given their limited side effects, further mechanistic studies and good quality randomized controlled trials of their putative analgesic ability are required to define the role of vitamin B and D in DPN.
KW - Vitamin B
KW - Vitamin D
KW - deficiency
KW - diabetic
KW - neuropathy
KW - peripheral
UR - http://www.scopus.com/inward/record.url?scp=85049628486&partnerID=8YFLogxK
U2 - 10.2217/fnl-2017-0034
DO - 10.2217/fnl-2017-0034
M3 - Article
SN - 1479-6708
VL - 13
SP - 135
EP - 142
JO - Future Neurology
JF - Future Neurology
IS - 3
ER -